Please use this identifier to cite or link to this item:
|Title:||Genetically modified stem cells for cellular therapy|
Embryonic stem cells
Neural stem cells
Somatic cell nuclear transfer
|Source:||Taupin, P. (2007). Genetically modified stem cells for cellular therapy. Gene Therapy and Molecular Biology 11 (1) : 75-78. ScholarBank@NUS Repository.|
|Abstract:||Stem cells carry the promise to cure a broad range of diseases and injuries, from diabetes, to neurological diseases and injuries. Over the past decade, significant progresses have been made in stem cell research; the derivation of embryonic stem cells (ESCs) from human tissues, the development of somatic cell nuclear transfer (SCNT) technology, and the confirmation that neurogenesis occurs in the adult mammalian brain, including in human. Despite these advances, there may be decades before stem cell research translates into therapy. Beside the scientific and technical challenges, there are ethical and political constraints and debates over stem cell research, particularly on ESCs and SCNT. In this manuscript, I will discuss how gene therapy is applied to stem cell research, in an attempt to unlock some of the technical, ethical and political hurdles associated with stem cell research.|
|Source Title:||Gene Therapy and Molecular Biology|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Jan 14, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.